Guangzhou Kangrun Biotech Co., Ltd. was established in 2002. It has long been committed to the independent research and development of in vitro diagnostic products (reagents and instruments). It is a comprehensive national high-tech company with independent intellectual property rights, integrating research and development, production and sales. Kangrun Biotech company is a AAA credit enterprise of China’s small and medium-sized enterprises, and is the vice chairman unit of the Guangdong Province (Guangzhou) Precision Health Management Industry Technology Innovation Alliance. Kangrun have 24 research and development staffs Including 12 with doctorate or master’s degree. They are experts with many years of experience in the development and testing of in vitro diagnostic products such as endocrine hormone, autoantibodies and EBV virus. In recent years, Kangrun has achieved fruitful research results, undertook 3 provincial, ministerial, and other industry-university-research projects, has obtained 7 registration certificates, applied for 7 invention patents, and 19 utility model patents, of which 10 have obtained patent authorization.